Antibacterial activity of rhodomyrtone on Clostridium difficile vegetative cells and spores in vitro

Sutthirat Srisuwan, Kate E. Mackin, Dianna M Hocking, Dena Lyras, Vicki R Bennett-Wood, Supayang P. Voravuthikunchai, Roy Michael Robins-Browne

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Abstract

The increasing incidence and severity of diarrhoea and colitis caused by Clostridium difficile, together with a high rate of relapse following treatment with currently recommended antimicrobials, calls for novel interventions for C. difficile infection (CDI). Rhodomyrtone, a bioactive compound derived from the leaves of the rose myrtle (Rhodomyrtus tomentosa) has demonstrated antibacterial activity against several Gram-positive bacteria. This study compared the in vitro antimicrobial activity of rhodomyrtone on C. difficile with that of vancomycin, a recommended agent for the treatment of CDI. Determination of the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of rhodomyrtone and vancomycin for ten C. difficile isolates showed that the MICs of rhodomyrtone for C. difficile vegetative cells (0.625–2.5 mg/L) were comparable with that of vancomycin (1.25 mg/L), but the MBCs of rhodomyrtone (1.25–5 mg/L) were significantly lower than those for vancomycin (5 mg/L to ˃40 mg/L; P < 0.001). Time–kill assays showed rapid bactericidal activity for rhodomyrtone, with ≥99% killing within 4 h. Rhodomyrtone was also four-fold more potent than vancomycin in inhibiting C. difficile spore outgrowth. Transmission electron microscopy of rhodomyrtone-treated C. difficile revealed cell lysis and evidence of defective cell division and spore formation. These studies indicate that rhodomyrtone should be further investigated as a potential treatment for CDI.

Original languageEnglish
Pages (from-to)724-729
Number of pages6
JournalInternational Journal of Antimicrobial Agents
Volume52
Issue number5
DOIs
Publication statusPublished - 1 Nov 2018

Keywords

  • Clostridium difficile
  • Rhodomyrtone
  • Spores
  • Vancomycin

Cite this

Srisuwan, S., Mackin, K. E., Hocking, D. M., Lyras, D., Bennett-Wood, V. R., Voravuthikunchai, S. P., & Robins-Browne, R. M. (2018). Antibacterial activity of rhodomyrtone on Clostridium difficile vegetative cells and spores in vitro. International Journal of Antimicrobial Agents, 52(5), 724-729. https://doi.org/10.1016/j.ijantimicag.2018.08.014
Srisuwan, Sutthirat ; Mackin, Kate E. ; Hocking, Dianna M ; Lyras, Dena ; Bennett-Wood, Vicki R ; Voravuthikunchai, Supayang P. ; Robins-Browne, Roy Michael. / Antibacterial activity of rhodomyrtone on Clostridium difficile vegetative cells and spores in vitro. In: International Journal of Antimicrobial Agents. 2018 ; Vol. 52, No. 5. pp. 724-729.
@article{a509d2ba6f8e4f76bccf02dc28671d5b,
title = "Antibacterial activity of rhodomyrtone on Clostridium difficile vegetative cells and spores in vitro",
abstract = "The increasing incidence and severity of diarrhoea and colitis caused by Clostridium difficile, together with a high rate of relapse following treatment with currently recommended antimicrobials, calls for novel interventions for C. difficile infection (CDI). Rhodomyrtone, a bioactive compound derived from the leaves of the rose myrtle (Rhodomyrtus tomentosa) has demonstrated antibacterial activity against several Gram-positive bacteria. This study compared the in vitro antimicrobial activity of rhodomyrtone on C. difficile with that of vancomycin, a recommended agent for the treatment of CDI. Determination of the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of rhodomyrtone and vancomycin for ten C. difficile isolates showed that the MICs of rhodomyrtone for C. difficile vegetative cells (0.625–2.5 mg/L) were comparable with that of vancomycin (1.25 mg/L), but the MBCs of rhodomyrtone (1.25–5 mg/L) were significantly lower than those for vancomycin (5 mg/L to ˃40 mg/L; P < 0.001). Time–kill assays showed rapid bactericidal activity for rhodomyrtone, with ≥99{\%} killing within 4 h. Rhodomyrtone was also four-fold more potent than vancomycin in inhibiting C. difficile spore outgrowth. Transmission electron microscopy of rhodomyrtone-treated C. difficile revealed cell lysis and evidence of defective cell division and spore formation. These studies indicate that rhodomyrtone should be further investigated as a potential treatment for CDI.",
keywords = "Clostridium difficile, Rhodomyrtone, Spores, Vancomycin",
author = "Sutthirat Srisuwan and Mackin, {Kate E.} and Hocking, {Dianna M} and Dena Lyras and Bennett-Wood, {Vicki R} and Voravuthikunchai, {Supayang P.} and Robins-Browne, {Roy Michael}",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.ijantimicag.2018.08.014",
language = "English",
volume = "52",
pages = "724--729",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier - Mosby",
number = "5",

}

Srisuwan, S, Mackin, KE, Hocking, DM, Lyras, D, Bennett-Wood, VR, Voravuthikunchai, SP & Robins-Browne, RM 2018, 'Antibacterial activity of rhodomyrtone on Clostridium difficile vegetative cells and spores in vitro', International Journal of Antimicrobial Agents, vol. 52, no. 5, pp. 724-729. https://doi.org/10.1016/j.ijantimicag.2018.08.014

Antibacterial activity of rhodomyrtone on Clostridium difficile vegetative cells and spores in vitro. / Srisuwan, Sutthirat; Mackin, Kate E.; Hocking, Dianna M; Lyras, Dena; Bennett-Wood, Vicki R; Voravuthikunchai, Supayang P. ; Robins-Browne, Roy Michael.

In: International Journal of Antimicrobial Agents, Vol. 52, No. 5, 01.11.2018, p. 724-729.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Antibacterial activity of rhodomyrtone on Clostridium difficile vegetative cells and spores in vitro

AU - Srisuwan, Sutthirat

AU - Mackin, Kate E.

AU - Hocking, Dianna M

AU - Lyras, Dena

AU - Bennett-Wood, Vicki R

AU - Voravuthikunchai, Supayang P.

AU - Robins-Browne, Roy Michael

PY - 2018/11/1

Y1 - 2018/11/1

N2 - The increasing incidence and severity of diarrhoea and colitis caused by Clostridium difficile, together with a high rate of relapse following treatment with currently recommended antimicrobials, calls for novel interventions for C. difficile infection (CDI). Rhodomyrtone, a bioactive compound derived from the leaves of the rose myrtle (Rhodomyrtus tomentosa) has demonstrated antibacterial activity against several Gram-positive bacteria. This study compared the in vitro antimicrobial activity of rhodomyrtone on C. difficile with that of vancomycin, a recommended agent for the treatment of CDI. Determination of the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of rhodomyrtone and vancomycin for ten C. difficile isolates showed that the MICs of rhodomyrtone for C. difficile vegetative cells (0.625–2.5 mg/L) were comparable with that of vancomycin (1.25 mg/L), but the MBCs of rhodomyrtone (1.25–5 mg/L) were significantly lower than those for vancomycin (5 mg/L to ˃40 mg/L; P < 0.001). Time–kill assays showed rapid bactericidal activity for rhodomyrtone, with ≥99% killing within 4 h. Rhodomyrtone was also four-fold more potent than vancomycin in inhibiting C. difficile spore outgrowth. Transmission electron microscopy of rhodomyrtone-treated C. difficile revealed cell lysis and evidence of defective cell division and spore formation. These studies indicate that rhodomyrtone should be further investigated as a potential treatment for CDI.

AB - The increasing incidence and severity of diarrhoea and colitis caused by Clostridium difficile, together with a high rate of relapse following treatment with currently recommended antimicrobials, calls for novel interventions for C. difficile infection (CDI). Rhodomyrtone, a bioactive compound derived from the leaves of the rose myrtle (Rhodomyrtus tomentosa) has demonstrated antibacterial activity against several Gram-positive bacteria. This study compared the in vitro antimicrobial activity of rhodomyrtone on C. difficile with that of vancomycin, a recommended agent for the treatment of CDI. Determination of the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of rhodomyrtone and vancomycin for ten C. difficile isolates showed that the MICs of rhodomyrtone for C. difficile vegetative cells (0.625–2.5 mg/L) were comparable with that of vancomycin (1.25 mg/L), but the MBCs of rhodomyrtone (1.25–5 mg/L) were significantly lower than those for vancomycin (5 mg/L to ˃40 mg/L; P < 0.001). Time–kill assays showed rapid bactericidal activity for rhodomyrtone, with ≥99% killing within 4 h. Rhodomyrtone was also four-fold more potent than vancomycin in inhibiting C. difficile spore outgrowth. Transmission electron microscopy of rhodomyrtone-treated C. difficile revealed cell lysis and evidence of defective cell division and spore formation. These studies indicate that rhodomyrtone should be further investigated as a potential treatment for CDI.

KW - Clostridium difficile

KW - Rhodomyrtone

KW - Spores

KW - Vancomycin

UR - http://www.scopus.com/inward/record.url?scp=85054816199&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2018.08.014

DO - 10.1016/j.ijantimicag.2018.08.014

M3 - Article

VL - 52

SP - 724

EP - 729

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 5

ER -